FDA Approved: IBANDRONATE SODIUM — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved Eugia US LLC's original Abbreviated New Drug Application for ibandronate sodium, a generic version of a drug used to treat osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• IBANDRONATE SODIUM (ibandronate sodium)

Snippet

ORIG AP for IBANDRONATE SODIUM (IBANDRONATE SODIUM)